Pursuant to Regulation 30(6) of the Schedule Ill, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed about the details of Analyst or Institutional Meetings with the Company scheduled on 28th September 2020.
The above information is a part of company’s filings submitted to BSE.